Sterile Endotracheal Tube Market Report 2026

The sterile endotracheal tube market size has grown strongly in recent years. It will grow from $2.29 billion in 2025 to $2.44 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to expansion of hospital and ICU capacity, rising incidence of respiratory disorders, increased use of mechanical ventilation, growth in surgical procedures, adoption of sterile disposable medical devices.

The sterile endotracheal tube market size is expected to see strong growth in the next few years. It will grow to $3.11 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing demand from emergency and critical care settings, rising focus on hospital-acquired infection prevention, expansion of healthcare infrastructure in emerging markets, growing adoption of advanced airway management products, increasing regulatory standards for medical devices. Major trends in the forecast period include increasing demand for single-use sterile airway devices, rising adoption of infection-control focused medical supplies, growing use of advanced tube design for patient safety, expansion of emergency and critical care infrastructure, enhanced focus on regulatory compliance and quality assurance.

The increasing prevalence of chronic respiratory conditions is expected to drive growth in the sterile endotracheal tube market in the coming years. Chronic respiratory conditions are long-term disorders affecting the lungs and respiratory system, often resulting in ongoing breathing difficulties. The rising incidence of these conditions is attributed to factors such as escalating environmental pollution, higher smoking rates, an aging population, sedentary lifestyles, climate change, occupational hazards, and socio-economic disparities. Sterile endotracheal tubes play a critical role in managing chronic respiratory diseases by maintaining a secure and hygienic airway during mechanical ventilation, thereby reducing the risk of infection. For example, in February 2025, the National Asthma Council Australia (NAC) reported that Australia recorded 474 asthma-related deaths in 2023, a slight increase of 0.2% from 473 deaths in 2022. Females accounted for 68.6% (325 deaths) of the total, while males represented 31.4% (149 deaths). This growing burden of chronic respiratory diseases is therefore contributing to the expansion of the sterile endotracheal tube market.

Major companies operating in the sterile endotracheal tube market are increasingly focused on developing innovative products such as suction-enabled endotracheal tubes to meet the growing demand for improved airway management, reduced infection risk, and enhanced patient safety during mechanical ventilation. These tubes incorporate integrated suction channels that continuously remove secretions from the subglottic space, offering better protection against aspiration and ventilator-associated pneumonia than conventional endotracheal tubes. For instance, in August 2023, SourceMark Medical, a U.S.-based medical device company, launched the SuctionPlus Endotracheal Tube, which features an evacuation lumen to reduce pneumonia risk, a high-volume/low-pressure cylindrical cuff, a removable 15 mm connector, and latex- and DEHP-free construction, expanding the company’s respiratory care portfolio. Additionally, in October 2023, AirLife, a U.S.-based manufacturer and distributor of anesthesia and respiratory consumables, acquired the respiratory health business of Avanos Medical, Inc., including the Ballard, Microcuff, and Endoclear product lines, strengthening AirLife’s position as a comprehensive provider of airway management and critical care solutions.

In October 2023, AirLife, a U.S.-based manufacturer and distributor of anesthesia and respiratory consumables, acquired the respiratory health business of Avanos Medical, Inc. for an undisclosed amount. The acquisition included well-established product lines such as Ballard, Microcuff, and Endoclear. Through this strategic move, AirLife aimed to strengthen its position as a comprehensive provider of airway management and critical care solutions by expanding its portfolio of trusted anesthetic and respiratory consumables. Avanos Medical, a U.S.-based medical device company, previously offered endotracheal tubes, including Microcuff products, closed suction systems, and related airway consumables through its respiratory health division.

Major companies operating in the sterile endotracheal tube market are Medtronic plc, Cook Medical Incorporated, Teleflex Incorporated, Zoll Medical Corporation, Hollister Incorporated, Avanos Medical Inc., Ambu A/S, Intersurgical Inc., Vyaire Medical Inc., Angiplast Pvt Ltd., Amsino International Inc., Inovet, GPC Medical Ltd., C. R. Bard Inc., Steroplast Healthcare Limited, Hitec Medical Co Ltd., Sterimed Group, Neurovision Medical Products Inc., Novo Klinik-Service GmbH, Well Lead Medical Co Ltd.

North America was the largest region in the sterile endotracheal tube market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile endotracheal tube market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sterile endotracheal tube market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the sterile endotracheal tube market by increasing costs of imported medical-grade plastics, sterilization equipment, packaging materials, and precision manufacturing components. Hospitals and medical device manufacturers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressures on export-driven production. These tariffs can elevate procurement and manufacturing costs. However, they are also encouraging domestic production, localized sterilization capabilities, and investment in regional medical device manufacturing ecosystems.

The sterile endotracheal tube market research report is one of a series of new reports that provides sterile endotracheal tube market statistics, including sterile endotracheal tube industry global market size, regional shares, competitors with a sterile endotracheal tube market share, detailed sterile endotracheal tube market segments, market trends and opportunities, and any further data you may need to thrive in the sterile endotracheal tube industry. This sterile endotracheal tube market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A sterile endotracheal tube is a medical device used to establish and maintain an airway in patients who are unable to breathe independently or who need mechanical ventilation. It is inserted into the patient’s trachea to keep the airway open and support mechanical breathing, while its sterile packaging and proper handling help reduce the risk of infection.

The primary types of sterile endotracheal tubes include no capsules, olive sacs, and columnar sacs. A no-capsules sterile endotracheal tube is a type that does not include any additional coatings or capsules and is used for airway management during medical procedures. It is applied across various settings such as emergency care, therapeutic use, and other medical applications. These tubes are used by end users including hospitals, clinics, ambulatory surgical centers, and others.

The sterile endotracheal tube market consists of sales of endotracheal tubes, lubricants, suction catheters, syringes, and airway management kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.